The Effect of FIFA 11+ Kids Training Programme on Injury Prevention and Athletic Performance in U-14 Basketball Players

NCT06998901 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-05-31

No results posted yet for this study

Summary

This study aims to evaluate the effects of the FIFA 11+ Kids training program on the athletic performance and Functional Movement Screen (FMS) scores of under-14 male basketball players. A total of 40 participants will be randomly assigned to either a training group or a control group. The training group will follow the FIFA 11+ Kids program for seven weeks, while the control group will continue with regular basketball training. Performance tests-including vertical jump, sprint, agility, standing long jump, and FMS-will be used to assess the impact of the intervention. The goal is to determine whether the FIFA 11+ Kids program can enhance athletic performance and movement quality in youth basketball players.

Conditions

  • Healthy Volunteers

Interventions

OTHER

FIFA 11+ Kids training program

Participants in this arm will receive the FIFA 11+ Kids training program in addition to their regular basketball practice. The program consists of structured neuromuscular warm-up exercises designed to improve balance, coordination, strength, and overall movement control. It will be implemented over a period of 7 weeks, with sessions conducted four times per week, each lasting approximately 15-20 minutes. The exercises are age-appropriate and follow a progressive format to enhance athletic performance and reduce injury risk in youth athletes.

Sponsors & Collaborators

  • Monira Aldhahi

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
13 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-01-01
Completion
2025-01-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06998901 on ClinicalTrials.gov